Diversity in diabetes feasibility study
| ISRCTN | ISRCTN16144112 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN16144112 |
| ClinicalTrials.gov (NCT) | Nil known |
| Clinical Trials Information System (CTIS) | Nil known |
| Integrated Research Application System (IRAS) | 344404 |
| Protocol serial number | IRAS 344404, NIHR202358, CPMS 63043 |
| Sponsor | University of Birmingham |
| Funder | National Institute for Health and Care Research |
- Submission date
- 31/05/2024
- Registration date
- 28/08/2024
- Last edited
- 28/08/2024
- Recruitment status
- Recruiting
- Overall study status
- Ongoing
- Condition category
- Nutritional, Metabolic, Endocrine
Plain English summary of protocol
Background and study aims
This study aims to find out if giving children and young people from socio-economic backgrounds typically underserved by healthcare services, dedicated support guided by their social needs can help them better manage their diabetes. Working directly with children and young people with type 1 diabetes and their families from typically underserved populations, researchers have developed an intervention that they believe will encourage children and young people from this background to better engage with their healthcare. They want to look at the feasibility of setting up this service within two centres in the NHS.
Who can participate?
Children and young people with type 1 diabetes being treated by the two centres taking part in this study
What does the study involve?
Those taking part in the study will talk with a dedicated youth worker at the hospital to develop a package of additional social support relevant to them which will be provided over 6 months. The researchers will record the child’s or young person's blood sugar level before the support package begins then again 6 months later after the support package ends to see how they are managing their diabetes.
The child or young person will fill in some questionnaires about how they feel about their life before and after the support.
Once the additional guidance stops after 6 months those who agree might be asked to speak with the study team to discuss what they felt about the support that they got and what the researchers could do to improve it.
Those who delivered the intervention will also be invited to speak with the trial team about what they felt about the interventions (additional social support), and if they were able to deliver it.
What are the possible benefits and risks of participating?
Those taking part in this study may benefit by being able to better manage their diabetes and control of their blood sugar. This might lead to less complications in the future
Those taking part in this study will need to spend more time at the hospital to talk with the support worker who will work with them to produce a package of care that makes sure that they are receiving all the support available to them.
There will also be some time needed to fill in the questionnaires, but this will only be a few minutes.
Where is the study run from?
University of Birmingham (UK)
When is the study starting and how long is it expected to run for?
January 2024 to June 2027
Who is funding the study?
National Institute for Health and Care Research (NIHR) (UK)
Who is the main contact?
Prof. Tim Barrett, t.g.barrett@bham.ac.uk
Contact information
Public, Scientific, Principal investigator
University of Birmingham
Birmingham
B15 2TT
United Kingdom
| t.g.barrett@bham.ac.uk |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Pragmatic prospective single-arm non-randomized feasibility study |
| Secondary study design | Non randomised study |
| Study type | Participant information sheet |
| Scientific title | Feasibility study of a complex intervention to improve glycaemic outcomes in children and young people from socio-economically deprived and/or ethnic minority groups |
| Study acronym | DIDs Feasibility |
| Study objectives | To determine whether a complex intervention designed to improve outcomes in children and young people with type 1 diabetes from socio-economically deprived groups and/or ethnic minorities, is feasible in relation to: 1. Recruitment (staff and participants) 2. Intervention delivery, acceptability and engagement |
| Ethics approval(s) |
Not yet submitted |
| Health condition(s) or problem(s) studied | Type 1 diabetes (children and young people) |
| Intervention | A bespoke package of interventions including: 1. Peer support 2. Life-coaching 3. Family support worker or Youth Worker input 4. Enhanced supportive ethos from the children’s diabetes clinic Those taking part in the study will talk with a dedicated youth worker at the hospital to develop a package of additional social support relevant to them which will be provided over 6 months. The researchers will record the child’s or young person's overall blood sugar level (glycated hemoglobin [HbA1c]) before the support package begins, then again 6 months later after the support package ends to see how they are managing their diabetes. The child or young person will fill in some questionnaires about how they feel about their life before and after the support. Once the additional guidance stops after 6 months those who agree might be asked to speak with the study team to discuss what they felt about the support that they got, and what the researchers could do to improve it. Those who delivered the intervention will also be invited to speak with the trial team to discuss what they felt about the interventions (additional social support), and if they were able to deliver it. |
| Intervention type | Behavioural |
| Primary outcome measure(s) |
The feasibility of sites appointing staff and training them to implement the study outcomes: |
| Key secondary outcome measure(s) |
Feedback from staff delivering the intervention, participants and carers to refine the intervention, collected using mixed methodology. For participants this will be after they exit the study when their 6 months of additional support finishes and will be undertaken by interview and written feedback via postcards and/or text messages. Staff who delivered the intervention will be interviewed at the end of a 12-month period to determine if they felt they had received sufficient training to deliver the intervention, what they felt about it, and what the barriers were to its delivery and how might these be overcome. |
| Completion date | 14/06/2027 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Mixed |
| Lower age limit | 5 Years |
| Upper age limit | 19 Years |
| Sex | All |
| Target sample size at registration | 36 |
| Key inclusion criteria | Carer willing to consent and participant to assent (if the participant is aged under 16 completed years or lacks the capacity to consent themselves) or participant willing and able to consent (aged 16 years and over) AND If white UK ethnicity: 1. Clinical diagnosis of type 1 diabetes of more than 12 months 2. Age 5-19 completed years at the time of commencement of the enrollment 3. Resident in index of multiple deprivation area deciles 1 and 2 4. Recipient of free school meals OR If UK minority ethnicity, other than white: 1, Clinical diagnosis of type 1 diabetes of more than 12 months 2. Age 5-19 completed years at the time of commencement of the intervention |
| Key exclusion criteria | 1. Diagnosis of other forms of diabetes (type 2, monogenic, secondary diabetes) 2. Psychiatric disorder that in the opinion of the local investigator might affect compliance with study procedures 3. Significant other chronic illness in addition to diabetes that may confound the results of the intervention 4. Participated in diabetes treatment trials in the 12 months prior to collection of baseline data |
| Date of first enrolment | 01/09/2024 |
| Date of final enrolment | 01/03/2026 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centres
Derby Road
Nottingham
NG7 2UH
United Kingdom
Infirmary Square
Leicester
LE1 5WW
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not expected to be made available |
| IPD sharing plan | As a feasibility study there are no plans to share participant data at the individual level |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |
Editorial Notes
09/08/2024: Study's existence confirmed by the NIHR.